Quick Answer
Ocugen, Inc. reported Diluted EPS of $0.26 per share (loss) for fiscal year 2023.
Ocugen, Inc. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2023 | -$0.26 | +35.0% |
| 2022 | -$0.40 | -33.3% |
| 2021 | -$0.30 | +3.2% |
| 2020 | -$0.31 | +78.8% |
| 2019 | -$1.46 | -84.8% |
| 2018 | -$0.79 | +20.2% |
| 2017 | -$0.99 | +54.6% |
| 2016 | -$2.18 | +9.9% |
| 2015 | -$2.42 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| June 30, 2024 | -$0.04 | +60.0% | +20.0% |
| March 31, 2024 | -$0.05 | +37.5% | +16.7% |
| September 30, 2023 | -$0.06 | +40.0% | +40.0% |
| June 30, 2023 | -$0.10 | -11.1% | -25.0% |
| March 31, 2023 | -$0.08 | +11.1% | +20.0% |
| September 30, 2022 | -$0.10 | -100.0% | -11.1% |
| June 30, 2022 | -$0.09 | +30.8% | +0.0% |
| March 31, 2022 | -$0.09 | -125.0% | -80.0% |
- Ocugen, Inc. showed an increase of +35.0% in Diluted EPS compared to the prior fiscal year.
- Over the 2015–2023 period, Ocugen, Inc.’s diluted eps has grown by 89.3% (from $2.42 per share (loss) to $0.26 per share (loss)).
- The most recent figure is from Ocugen, Inc.’s fiscal year 2023 report (Form 10-K), filed with the SEC on April 16, 2024.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: